AI in Biotechnology Market Size to Surge USD 26.94 Bn by 2035 with 20.6% Annual Growth

What is the AI in Biotechnology Market Size?

The AI in biotechnology market was valued at USD 4.13 billion in 2025 and is anticipated to grow to over USD 26.94 billion by 2035, achieving a compound annual growth rate (CAGR) of 20.6% during the forecast period 2026 to 2035. Considering the rise in government as well as private initiatives for drug discovery and development that is aligned with advanced technologies, the AI in biotechnology market is seen to grow rapidly.

The AI in biotechnology market is defined as the application of artificial intelligence technologies into the biotechnology sector for research, development, and commercial applications. This market includes the range of software platforms, algorithms, computing infrastructure and AI tools which aid researchers in the analysis of biological data, the discovery of novel drugs, enhancement of clinical trials, understanding the implications of human genomes and creation of new treatment methods.

AI in Biotechnology Market Statistics

• By component, the software segment held the dominant market share in 2025. The use of AI based platforms to analyze large volumes of biological data and conduct research operations is on rise among biotechnology firms. Steady developments in machine learning algorithms and cloud based analytical platforms are contributing to the growth of software.
• By component, the hardware segment is projected to witness significant growth during the forecast period. The increasing volume of biological and genomic data is leading to a rise in the demand for efficient computing infrastructure to support heavy loads. Organizations are spending on developing efficient processors to aid their AI computations.
• By application, the drug discovery and development segment was the leading market share in 2025. Researchers are utilizing AI to reduce the time of drug discovery and identify new candidates in more effective way. The necessity to enhance research productivity and cut down the costs of drug development is driving the growth of the segment.
• By application, the clinical trials and optimization segment is expected to rise at the fastest pace during the forecast period. Organizations are using AI tools to develop better trial plans, monitor patient progress, and process the collected data efficiently. Rising emphasis on improving clinical trials in a much faster way will drive the growth of the segment.
• By end user, the pharmaceutical companies segment accounted for the dominant market share in 2025. Pharmaceutical organizations are making considerable investments in AI solutions to get better results in research and shorten the product development timeline. The complexity in modern drug development is forcing them to look for better advanced analytics tools.
• By end user, the biotechnology companies segment is predicted to grow at the fastest pace during the forecast period. Biotechnology firms are making use of AI technologies for its applications in genomic research, protein analysis, and precision medicine initiatives. Rising level of research and innovation among biotechnology firms are contributing to the segment's expansion.

AI-Powered Drug Discovery and Precision Medicine: Market’s Biggest Potential

A major growth opportunity in the AI in biotechnology market is in the increasing application of artificial intelligence in drug discovery and precision medicine. Traditional drug development process is very time-consuming, requiring years of research, trials and substantial investment. Artificial intelligence is accelerating this process, where biotechnology and pharmaceutical companies are using it to help identify candidate drugs, predict drug interactions and improve the research process.

AI systems are able to analyze a large amount of data including, genetic sequences, pathways of diseases, research literature, clinical records, and molecule structures in order to find targets for drug treatment. By using the power of AI technology, scientists are able to quickly predict and find drug targets which have a higher success rate. AI technology can also be used to develop treatment for specific groups of people, leading to precision medicine.

AI in Biotechnology Market Regional Outlook

North America was the largest regional market and is anticipated to continue leading the AI in biotechnology market over the next few years. North America boasts of a favorable biotechnology ecosystem, the best research institutes, world-class infrastructure in the healthcare sector and has huge amount of investment in artificial intelligence technologies. With the leading biotechnology companies, pharmaceutical manufacturers, AI developers present in this region, USA continues to be the primary growth driver. Huge investments being made by drug discoveries, genomic research, precision medicines, and digital health applications are further bolstering the growth of this market in this region. The increasing partnerships between biotechnology companies and AI technology vendors will further boost North America to top this market.

Asia Pacific region is estimated to grow at the fastest pace over the forecast period. China, Japan, India and South Korea are investing heavily on biotechnology research, healthcare innovation and AI in the health sector. Favorable government support on digital health, growth in biotechnology start-up eco-system, increase in research funding is likely to spur growth in this region. Increased demand for personalized medicines, genomic research and modern health solutions will accelerate AI use across the region in the years to come.

Who are the Top Companies in the AI in Biotechnology Market? 

The competitive landscape of AI in biotechnology market consists of some major players, Insilico Medicine, Recursion Pharmaceuticals, Exscientia, BenevolentAI, Schrdinger, IBM, Microsoft, Google DeepMind, NVIDIA and Tempus AI.

These companies have a significant influence in the development of biotechnological research with artificial intelligence, machine learning, big data analytics technology in the market and researchers are utilizing the technology to study the biological data and develop drug candidates, improve clinical trials and create targeted therapies. Their constant innovation and collaborations with major pharmaceutical and biotech companies help them make scientific discoveries at a higher speed and thereby revolutionizing the biotechnology and healthcare market in the long run.

Segments Covered in the Report

By Component

• Hardware
• Software
• Services

By Application

• Drug Discovery & Development
• Clinical Trials & Optimization
• Medical Imaging
• Diagnostics
• Others

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutes
• Healthcare Providers 
• CRO & CDMO
• Others

By Region

• North America
  • United States 
  • Canada 
• Europe
  • Germany 
  • United Kingdom 
  • France 
  • Italy 
  • Spain 
• Asia Pacific
  • China 
  • Japan 
  • South Korea 
  • India 
  • Singapore 
• Latin America
  • Brazil 
  • Mexico 
  • Argentina 
• Middle East & Africa
  • UAE 
  • Saudi Arabia 
  • South Africa

Contact Us:

Mr. Richard Johnson

Acumen Research and Consulting

India: +91 8983225533

E-mail: [email protected]